Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
6.32
+0.15 (2.43%)
At close: Nov 21, 2025, 4:00 PM EST
6.34
+0.02 (0.32%)
After-hours: Nov 21, 2025, 4:10 PM EST
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $438.41 million as of November 21, 2025. Its market cap has decreased by -73.14% in one year.
Market Cap
438.41M
Enterprise Value
-204.18M
1-Year Change
-73.14%
Ranking
Category
Stock Price
$6.32
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $438.41M, an increase of 106.45%. That is a compound annual growth rate of 11.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 438.41M | -54.65% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | 382.42M | 126.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |